Chemed Corporation Reports Third Quarter 2026 Financial Results

Chemed Corporation reported third-quarter 2026 revenue of $690.9 million, above the $685.0 million FactSet consensus, and adjusted EPS of $6.75, beating the $6.44 estimate. Roto-Rooter revenue rose 7.5% year over year to $233.5 million. Chemed now expects 2026 adjusted EPS to be at or slightly above the high end of its prior $25.00–$25.75 guidance range. The company repurchased 125,000 shares for $66.0 million during the quarter.